Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Capital Expenditures: 2020-2023

Historic Capital Expenditures for Cullinan Therapeutics (CGEM) over the last 3 years, with Dec 2023 value amounting to $208,000.

  • Cullinan Therapeutics' Capital Expenditures was N/A to $49,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $208,000 for FY2023, which is 81.64% down from last year.
  • Per Cullinan Therapeutics' latest filing, its Capital Expenditures stood at $208,000 for FY2023, which was down 81.64% from $1.1 million recorded in FY2022.
  • Cullinan Therapeutics' Capital Expenditures' 5-year high stood at $1.1 million during FY2022, with a 5-year trough of $10,000 in FY2020.
  • In the last 2 years, Cullinan Therapeutics' Capital Expenditures had a median value of $670,500 in 2022 and averaged $670,500.
  • Data for Cullinan Therapeutics' Capital Expenditures shows a maximum YoY plummeted of 81.64% (in 2023) over the last 5 years.
  • Cullinan Therapeutics' Capital Expenditures (Yearly) stood at $10,000 in 2020, then reached $1.1 million in 2022, then tumbled by 81.64% to $208,000 in 2023.